Skip to main content
. 2020 May 13;128:104438. doi: 10.1016/j.jcv.2020.104438

Table 1.

Limits of detection for SARS-CoV-2 by specimen type.

Sample Type
NP Swab BAL Sputum Plasma CSF Stool** PBS VTM/UTM HBSS (Hanks')
Target N1 N2 N1 N2 N1 N2 N1 N2 N1 N2 N1 N2 N1 N2 N1 N2 N1 N2 At LoD
Dilution 1e-5 2e-5 1e-5 2e-5 1e-5 1e-5 5e-4 1e-5 1e-5 1e-6 1e-5 1e-5 1e-5 1e-5 1e-5 1e-5 1e-5 1e-5
Copies/ Reaction* 10 5 10 5 10 10 20 10 10 1 10 10 10 10 10 10 10 10
Mean CT 33.8 35.1 33.8 35.4 34.5 35.4 34.4 34.9 35.5 36 35.7 36.2 35 34.8 34.6 34 34.8 34.8
Pos. Detected 20/20 20/20 20/20 20/20 19/20 19/20 20/20 20/20 19/20 20/20 20/20 20/20 20/20 20/20 20/20 20/20 20/20 20/20
Dilution 2e-5 5e-5 2e-5 5e-5 1e-6 1e-6 1e-5 2e-5 2e-5 1e-7 1e-6 1e-6 2e-5 2e-5 1e-6 1e-6 1e-6 1e-6 Beyond LoD
Copies/ Reaction* 5 2 5 2 1 1 10 5 5 0.1 1 1 5 5 1 1 1 1
Mean CT 35.9 36.4 35.6 36.9 36.5 37.2 35.4 36.5 36.5 38.3 37.1 37.8 35.7 36.4 37.2 37.5 36.5 36.1
Pos. Detected 18/20 17/20 18/20 16/20 8/20 14/20 17/20 18/20 14/20 1/20 5/20 8/20 18/20 18/20 7/20 14/20 17/20 18/20
Unique Specimens 77 104 47 100 100 60 N/A N/A N/A Specificity
Unique Respiratory Pos. 20 25 16 N/A N/A N/A N/A N/A N/A

Abbreviations: NDET, Not detected; CT, cycle threshold; NP nasopharyngeal; BAL, bronchoalveolar lavage; PBS, phosphate buffered saline; VTM, viral transport medium; UTM, universal transport medium; HBSS, Hanks’ balanced buffer solution; CSF, cerebral spinal fluid; rxn, reaction.

Conversion of copies/rxn to copies/mL is a factor of 50.

*Estimated copies/rxn were quantified using digital droplet PCR of SARS-CoV-2 dilutions series in duplicates.

**Stool serial dilutions are adjusted as 20 uL of stool sample was already diluted with 180uL STAR buffer for extraction (1:10 dilution).